We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wyeth Phasing Out New York Plant, Exploring Possible Sale
Wyeth Phasing Out New York Plant, Exploring Possible Sale
November 7, 2005
Wyeth plans to phase out its Rouses Point, N.Y., manufacturing operation over the next three years — a move prompted by slumping sales of the company’s hormone-replacement drug Premarin, which is made at the plant.